Gleason Score 6 Adenocarcinoma: Should It Be Labeled As Cancer?

This publication has 32 references indexed in Scilit:

• Growth Of High-Cost Intensity-Modulated Radiotherapy For Prostate Cancer Raises Concerns About Overuse
  Health Affairs, 2012
• Emerging Critical Role of Molecular Testing in Diagnostic Genitourinary Pathology
  Archives of Pathology & Laboratory Medicine, 2012
• The Relationship Between Clinical Benefit and Receipt of Curative Therapy for Prostate Cancer
  Archives of internal medicine (1960), 2012
• Call It Cancer
  The Oncologist, 2012
• Outcomes in Localized Prostate Cancer: National Prostate Cancer Register of Sweden Follow-up Study
  JNCI: Journal of the National Cancer Institute, 2010
• Time Trends and Local Variation in Primary Treatment of Localized Prostate Cancer
  Journal of Clinical Oncology, 2010
• Prospective Study of Determinants and Outcomes of Deferred Treatment or Watchful Waiting Among Men With Prostate Cancer in a Nationwide Cohort
  Journal of Clinical Oncology, 2009
• Contemporary Trends in Low Risk Prostate Cancer: Risk Assessment and Treatment
  Journal of Urology, 2007
• Risk Stratification of Men with Gleason Score 7 to 10 Tumors by Primary and Secondary Gleason Score: Results from the SEARCH Database
  Urology, 2007
• A model of the natural history of screen-detected prostate cancer, and the effect of radical treatment on overall survival
  British Journal of Cancer, 2006